-
Airway Therapeutics Secures $1.9 Million NIH Grant to Advance Zelpultide Alfa Research
A Major Milestone for Neonatal Care Airway Therapeutics, a biopharmaceutical company dedicated to developing innovative treatments for respiratory diseases, has reached a significant milestone. The company has been awarded a $1.9 million grant from the National Institutes of Health (NIH) to support the progression of its clinical research. The Focus: Combating Bronchopulmonary Dysplasia (BPD) The…